Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients

被引：35
|
作者：
La, Y. J.
Wan, C. L.
Zhu, H.
Yang, Y. F.
Chen, Y. S.
Pan, Y. X.
Feng, G. Y.
He, L.
机构：
[1] Shanghai Jiao Tong Univ, Bio X Ctr, Shanghai 200030, Peoples R China
[2] Chinese Acad Sci, Inst Nutr Sci, Shanghai, Peoples R China
来源：
JOURNAL OF NEURAL TRANSMISSION | 2007年 / 114卷 / 05期
关键词：
ApoA-I; chlorpromazine; clozapine; proteomics; schizophrenia;
D O I：
10.1007/s00702-006-0607-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
This study aims to identify the effects of antipsychotics on plasma proteins, and on the proteins associated with schizophrenia. We applied proteomics technology to screen protein aberrations in Sprague-Dawley rats treated with antipsychotics and schizophrenic patients undergoing medication. ApoA-I was found significantly increased in the chlorpromazine-treated rats and decreased in the patients with treatment-resistant schizophrenia, which suggest that decreased levels of apoA-I might be associated with the pathology of schizophrenia and that chlorpromazine increases apoA-I levels as part of its therapeutic action.
引用
收藏
页码：657 / 663
页数：7
相关论文
共 50 条
  • [31] Decreased plasma apolipoprotein A-IV levels in patients with acute coronary syndrome
    Li, Jiabei
    Song, Mingbao
    Qian, Dehui
    Lu, Wei
    Wang, Juan
    Jiang, Guoyan
    Jin, Jun
    Wu, Xiaojing
    Huang, Lan
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE, 2013, 36 (04): : E207 - E215
  • [32] Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
    von Eckardstein, A
    Chirazi, A
    Schuler-Lüttmann, S
    Walter, M
    Kastelein, JJP
    Geisel, J
    Real, JT
    Miccoli, R
    Noseda, G
    Höbbel, G
    Assmann, G
    [J]. JOURNAL OF LIPID RESEARCH, 1998, 39 (05) : 987 - 998
  • [33] Increased plasma lipid-poor apolipoprotein A-I in patients with coronary artery disease
    Suzuki, M
    Wada, H
    Maeda, S
    Saito, K
    Minatoguchi, S
    Saito, K
    Seishima, M
    [J]. CLINICAL CHEMISTRY, 2005, 51 (01) : 132 - 137
  • [34] Hibernation increases cholesterol and apolipoprotein A-I levels in ground squirrels
    Otis, Jessica P.
    Carey, Hannah V.
    [J]. FASEB JOURNAL, 2009, 23
  • [35] Abnormal levels of apolipoprotein A-I in chronic thromboembolic pulmonary hypertension
    Khirfan, Ghaleb
    Li, Manshi
    Wang, Xiaofeng
    DiDonato, Joseph A.
    Dweik, Raed A.
    Heresi, Gustavo A.
    [J]. PULMONARY CIRCULATION, 2021, 11 (02)
  • [36] DECREASED INTERSTITIAL APOLIPOPROTEIN-A-I LEVELS IN IDDM PATIENTS WITH DIABETIC NEPHROPATHY
    TAMSMA, JT
    BEVERDAM, FH
    LEUVEN, JAG
    LEMKES, HHPJ
    [J]. DIABETES, 1995, 44 (05) : 501 - 505
  • [37] CLINICAL FEATURES OF LIVER DISEASE IN PATIENTS AFFECTED BY APOLIPOPROTEIN A-I (Apo A-I) AMYLOIDOSIS
    Biasi, L.
    Rodari, P.
    Amadasi, S.
    Scalvini, T.
    Gregorini, G.
    Scolari, F.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S556 - S556
  • [38] TWEEN-20 INCREASES THE IMMUNOREACTIVITY OF APOLIPOPROTEIN A-I IN PLASMA
    MAO, SJT
    KOTTKE, BA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 620 (03) : 447 - 453
  • [39] Acid lipase inhibitor in chicken plasma identified as apolipoprotein A-I
    Fujii, M
    Higuchi, T
    Mukai, S
    Yonekura, M
    Yano, T
    Kawaguchi, H
    Nonaka, K
    Fukunaga, T
    Sugimoto, Y
    Yamada, S
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1996, 60 (10) : 1575 - 1579
  • [40] Identification of apolipoprotein A-I as a plasma ligand for macrophage scavenger receptor A
    Neyen, C.
    Plueddemann, A.
    Thomas, B.
    Akoulitchev, A.
    Cai, L.
    Van der Westhuyzen, D.
    Sim, R.
    Gordon, S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 514 - 514
12345